The spontaneous resolution of the patients chronic anemia was unexpected, but does fit with research by Luo et al
Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association 131(12):656666 Luo W, Tang S, Xiao X, Luo S, Yang Z, Huang W, Tang S (2023) Translation animal models of diabetic kidney disease: biochemical and histological phenotypes, advantages and limitations
L-Carnitine Supplementation to Diet: A New Tool in Treatment of Nonalcoholic SteatohepatitisA Randomized and Controlled Clinical Trial
One week, you may be fine
Consistency: Like most peptide-based actives, GHK-Cu delivers cumulative results
Afamelanotide is FDA-approved for EPP at 16 mg subcutaneous implant every 60 days roughly 2 mg/day of continuous release (Langendonk et al., 2015)